[2-(4-methoxyphenyl)cyclopropyl]acetaldehyde | 853400-97-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: [2-(4-methoxyphenyl)cyclopropyl]acetaldehyde
• 英文别名: 2-[2-(4-Methoxyphenyl)cyclopropyl]acetaldehyde
• CAS: 853400-97-2
• 化学式: C₁₂H₁₄O₂
• 分子量: 190.242
• InChiKey: KMYBICPOEQODRJ-UHFFFAOYSA-N

物化性质

• 沸点：
  309.5±25.0 °C(Predicted)
• 密度：
  1.078±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  [2-(4-methoxyphenyl)cyclopropyl]acetaldehyde 在 盐酸 、 sodium hydroxide 、 silver nitrate 作用下， 以 乙醇 、 水 为溶剂， 反应 18.5h， 生成 ethyl 1-(p-methoxyphenyl)cyclopropane-2-acetate
  参考文献：
  名称：

  Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective αvβ3 inhibitor: Design, synthesis, and optimization

  摘要：

  The integrin alpha(v)beta(3) is expressed in a number of cell types and is thought to play a major role in several pathological conditions. Various small molecules that inhibit the integrin have been shown to suppress tumor growth and retinal angiogenesis. The tripeptide Arg-Gly-Asp (RGD), a common binding motif in several ligands that bind to alpha(v)beta(3), has been depeptidized and optimized in our efforts toward discovering a small molecule inhibitor. We recently disclosed the synthesis and biological activity of several small molecules that did not contain any peptide bond and mimic the tripeptide RGD. The phenethyl group in one of the lead compounds was successfully replaced with a cyclopropyl moiety. The new lead compound was optimized for potency, selectivity, and for its ADME properties. We describe herein the discovery, synthesis, and optimization of cyclopropyl containing analogs that are potent and selective inhibitors of alpha(v)beta(3). (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.03.020
• 作为产物：
  描述：

  N-methoxy-2-(4-methoxyphenyl)-N-methylcyclopropanecarboxamide 在 二异丁基氢化铝 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 4.0h， 生成 [2-(4-methoxyphenyl)cyclopropyl]acetaldehyde
  参考文献：
  名称：

  Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective αvβ3 inhibitor: Design, synthesis, and optimization

  摘要：

  The integrin alpha(v)beta(3) is expressed in a number of cell types and is thought to play a major role in several pathological conditions. Various small molecules that inhibit the integrin have been shown to suppress tumor growth and retinal angiogenesis. The tripeptide Arg-Gly-Asp (RGD), a common binding motif in several ligands that bind to alpha(v)beta(3), has been depeptidized and optimized in our efforts toward discovering a small molecule inhibitor. We recently disclosed the synthesis and biological activity of several small molecules that did not contain any peptide bond and mimic the tripeptide RGD. The phenethyl group in one of the lead compounds was successfully replaced with a cyclopropyl moiety. The new lead compound was optimized for potency, selectivity, and for its ADME properties. We describe herein the discovery, synthesis, and optimization of cyclopropyl containing analogs that are potent and selective inhibitors of alpha(v)beta(3). (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.03.020

文献信息

• Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
  申请人：——

  公开号：US20040092538A1

  公开（公告）日：2004-05-13

  The present invention relates to a class of compounds represented by the Formula I 1 or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the &agr; v &bgr; 3 and/or &agr; v &bgr; 5 integrin.

  本发明涉及一类由公式I代表的化合物 1 或其药用可接受的盐，包含公式I化合物的药物组合物，以及选择性地抑制或拮抗α v β 3 和/或α v β 5 整合素的方法。
• α-Tetrasubstituted Aldehydes through Electronic and Strain-Controlled Branch-Selective Stereoselective Hydroformylation
  作者：Josephine Eshon、Floriana Foarta、Clark R. Landis、Jennifer M. Schomaker

  DOI：10.1021/acs.joc.8b01431

  日期：2018.9.7

  high conversions and yields of tetrasubstituted aldehydes (e.g., 13:1 regioselectivity, 85% ee, and <1% hydrogenation for 1-fluoromethyl acrylate). The scope also encompasses both acyclic 1,1′-disubstituted and trisubstituted, electron-poor alkenes as well as di- and trisubstituted alkenes composed of small rings with exocyclic and endocyclic unsaturation. For example, 1-methylene-β-lactam furnished

  加氢甲酰化利用二氢，一氧化碳和催化剂将烯烃转化为醛。这项工作将手性双二氮杂膦烷（BDP）和双膦酰氨基乙烷连接的铑络合物应用于各种烯烃的加氢甲酰化反应，以生产手性四取代的醛。带有吸电子取代基的1,1'-二取代丙烯酸酯在温和条件下（1摩尔％的催化剂/ BDP配体，150 psig气体，60°C）以高转化率和四取代醛（例如13：1区域选择性）收率进行加氢甲酰化，1-85％ee和小于1％的氢化反应（对于丙烯酸1-氟甲基丙烯酸酯）。该范围还涵盖无环的1,1'-二取代和三取代的贫电子烯烃，以及由具有环外和环内不饱和键的小环组成的二和三取代的烯烃。例如，1-亚甲基-β-内酰胺为四取代的醛提供了98％的选择性和高达83％的ee。值得注意的是，手性三取代双环亚甲基氮丙啶以> 50催化剂周转/小时的速率以> 99％的区域选择性和> 19：1的非对映选择性转化为四取代的醛。HRh（BDP）（CO）非催化反应的N
• Visible-Light Induced Direct Synthesis of Polysubstituted Furans from Cyclopropyl Ketones
  作者：Liyan Feng、Hang Yan、Chao Yang、Dafa Chen、Wujiong Xia

  DOI：10.1021/acs.joc.6b00436

  日期：2016.8.19

  In this article, a photoredox protocol for the synthesis of furans via oxidative coupling of olefin generated in situ from cyclopropyl ketones with ketonic oxygen atom is presented. Moreover, bromination of furans in the presence of overstoichiometric oxidant has been achieved with high regioselectivity.

  在本文中，提出了一种光氧化还原方案，用于通过环丙基酮与酮氧原子原位生成的烯烃的氧化偶联来合成呋喃。此外，在化学计量过量的氧化剂存在下，呋喃的溴化反应具有很高的区域选择性。
• [EN] NOVEL PROCESSES FOR THE SYNTHESIS OF CYCLOPROPYL COMPOUNDS<br/>[FR] NOUVEAUX PROCESSUS DE SYNTHESE DE COMPOSES DE CYCLOPROPYLE
  申请人：PHARMACIA CORP

  公开号：WO2005051904A2

  公开（公告）日：2005-06-09

  This invention relates to processes for the preparation of cyclopropyl compounds of Formula: (I) wherein: x is an integer selected from the group consisting of 0, 1 and 2; R1 and R2 are independently selected from the group consisting of H, C1-C6 alkyl, and halo; and R3, R4, R5, R6 and R7 are independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy, and halo.